The global zika virus testing market was valued at USD 503.2 million in 2025 and is expected to reach USD 537.8 million by the end of 2026. By 2035, the market is projected to reach USD 985.4 million. From 2025 to 2035, the market is anticipated to expand at a CAGR of 6.9%.

Increasing outbreaks of mosquito-borne infections, rising awareness regarding prenatal screening, and growing investments in molecular diagnostic technologies are significantly contributing to market growth.

Healthcare organizations and diagnostic laboratories are increasingly focusing on rapid molecular assays, high-sensitivity PCR testing platforms, and advanced serological testing technologies to improve outbreak management, early diagnosis, and public health monitoring capabilities.

Market Growth Drivers

• Increasing prevalence of mosquito-borne viral diseases worldwide
• Rising demand for rapid and accurate infectious disease diagnostics
• Growing awareness regarding prenatal Zika virus screening and maternal health monitoring
• Expanding government initiatives for infectious disease surveillance and outbreak preparedness
• Increasing adoption of molecular diagnostic and PCR-based testing technologies

Get detailed market forecasts, competitive benchmarking, and pricing trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-2913

Emerging Trends

• Growing development of portable and point-of-care Zika virus testing kits
• Increasing integration of multiplex molecular diagnostic platforms
• Rising adoption of AI-supported infectious disease surveillance systems
• Expansion of rapid antigen and nucleic acid amplification testing technologies
• Increasing focus on early outbreak detection and pandemic preparedness strategies

Regional Insights

• North America: Strong growth supported by advanced infectious disease diagnostic infrastructure, increasing investments in public health surveillance, and rising focus on travel-related viral disease monitoring.

• Europe: Stable market expansion driven by increasing adoption of molecular diagnostics and rising government preparedness programs for emerging infectious diseases.

• Asia-Pacific: Fastest-growing region owing to rising mosquito-borne disease prevalence, improving healthcare infrastructure, and increasing adoption of advanced diagnostic technologies across India, China, Southeast Asia, and Japan.

• Latin America: Significant market opportunities supported by high prevalence of Zika virus outbreaks and increasing government healthcare interventions in Brazil and neighboring countries.

• Middle East & Africa: Growing market fueled by improving disease surveillance infrastructure and rising awareness regarding infectious disease management.

Competitive Landscape

The zika virus testing market remains highly competitive with companies focusing on rapid molecular diagnostics, multiplex infectious disease testing platforms, and expansion of global diagnostic capabilities.

Key Players Include:

F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., bioMérieux SA, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QIAGEN N.V., Danaher Corporation, Bio-Rad Laboratories Inc.

Strategic Outlook

The zika virus testing market is evolving from conventional laboratory diagnostics toward rapid, decentralized, and high-sensitivity infectious disease testing ecosystems. Future market growth will be shaped by:

• Increasing adoption of rapid molecular diagnostic platforms
• Rising investments in infectious disease surveillance and outbreak preparedness
• Expansion of point-of-care and portable diagnostic testing solutions
• Integration of AI-driven epidemiological monitoring technologies
• Stronger focus on maternal healthcare and prenatal viral infection screening

In 2026, molecular diagnostic testing is expected to account for a dominant share of the market owing to increasing demand for highly accurate viral detection, faster turnaround times, and growing adoption in outbreak management programs.

Conclusion

With rising prevalence of mosquito-borne infections, increasing investments in infectious disease diagnostics, and growing demand for rapid molecular testing technologies, the zika virus testing market is expected to witness sustained long-term growth. The market presents strong opportunities for companies investing in PCR-based diagnostics, portable testing platforms, and next-generation infectious disease surveillance solutions.

Request Sample Report with Complete Market Breakdowns and Growth Estimates:
https://www.futuremarketinsights.com/reports/zika-virus-testing-market

Have specific requirements or need assistance on report pricing or limited budget? Please contact us – sales@futuremarketinsights.com

About Future Market Insights (FMI)

Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

Why Choose FMI:
https://www.futuremarketinsights.com/why-fmi